Authors: Dr Tatiana Ninkov, Dermatology Resident; Dr Rachael Foster, Dermatologist, Sir Charles Gairdner Hospital, Perth, Australia (2025) Previous contributors: Hon Assoc Prof Amanda Oakley, Dermatologist, NZ (2014)
Peer reviewed by: Dr Zoe Lee, Flinders Medical Centre, Australia (2025)
Palmoplantarpustulosis is a benign, chronic, and often relapsing sterile pustulardermatosis affecting the palms and soles. It may occur in patients with psoriasis, however it likely represents a distinct clinical entity. It responds less reliably to biologic treatments effective in psoriasis.
The exact cause of palmoplantar pustulosis remains unknown. However, environmental factors such as smoking, manual or repetitivetrauma, irritants, and friction have been associated with this condition. Aside from these factors, several theories have also been proposed:
It may be a disorder of the eccrine sweat glands, which are most numerous on the palms and soles
Increased numbers of Langerhans cells around sweat ducts in this condition suggest a possible antigen-driven process
Geneticmutations involving IL36RN, CARD14, ATG16L1 and AP1S3 may be associated
It is not associated with the major psoriasis susceptibility locus PSORS1 or HLA-C:09:02, suggesting a genetically distinct entity from plaque psoriasis.
Specific chemotactic factors may also contribute or propagate inflammation including increased expression of IL8 and IL17. Increased detection of tumournecrosis factor-alpha (TNF-alpha) and IL-17. IL-22 and interferon-gamma have also been detected. Complement pathway activation has also been noted.
Pustules and rusty dots in a scaly plaque typical of PPP
Pustules on the palm due to PPP
Typical lesions of PPP on the soles - redness, scale, pustules and rusty red dots
Palmoplantar pustulosis commonly presents between the ages of 20 and 60 years, with a predilection for females (female-to-male ratio 4:1).
The majority of patients with palmoplantar pustulosis are cigarette smokers, with 70-90% of patients being current or former smokers. Smoking is also a disease-aggravating factor. It is thought that activated nicotine receptors in the sweat glands stimulate an inflammatory process.
Several associated conditions have been determined:
One large population-based study utilising Swedish longitudinal register data found that patients with type 2 diabetes mellitus and/or COPD, as well as a generally higher comorbidity burden, are more likely to have palmoplantar pustulosis
Other conditions that may be associated include hypertension, hyperlipidaemia, atopic dermatitis, thyroid disease, coeliac disease, metabolic disease, and depression.
Other described causes include:
Drug-induced, particularly TNF-alphainhibitors.
Focalinfections
Metal allergies
Stress.
What are the clinical features of palmoplantar pustulosis?
Palmoplantar pustulosis usually presents as crops of sterile pustules localised to the palms and soles. These pustules are 1-10mm in size, often admixed with yellow-brown macules and/or scaly, erythematousplaques.Lichenification and desquamation are also commonly seen.
Pustules are more commonly noted on the thenar and hypothenar eminences and central palm. As well as the instep, medial and lateral borders of the foot and the sides or back of the heel.
Patients complain of varying levels of pruritus, however a more common complaint is of a ‘burning’ sensation. Lesions may also develop into painful fissures, and psoriatic nail changes may be present.
Palmoplantar pustulosis varies in severity and is often chronic, due to its difficult-to-treat nature. Slow spread or extension may occur. Rarely, pustules form snake-like patterns — termed serpiginous palmoplantar pustulosis.
Palmoplantar pustulosis is generally a clinical diagnosis. Investigations may be helpful for ruling out differential diagnoses or excluding possible complications. This includes:
Potassium hydroxide preparation (rule out cutaneousfungal infection)
Potent forms in ointmentvehicles are most suitable and applied under occlusion for increased penetration (short-term only).
Occlusion involves covering the applied topical steroid with a plastic film (such as cling film, plastic bags, or polyethylene gloves) for a few hours or even overnight.
The disease course of palmoplantar pustulosis is usually prolonged, unpredictable, and can be refractory to treatment. Even if remission is achieved, relapse is common.
Bibliography
Chen, T., & Ma, D.-L. (2025). Serpiginous pustules and erythematous plaques on the soles of the feet. British Journal of Dermatology, 192(4), 776. doi:10.1093/bjd/ljae497. Journal
Freitas E, Rodrigues MA, Torres T. Diagnosis, screening and treatment of patients with palmoplantar pustulosis (PPP): A review of current practices and recommendations, Clinical, Cosmetic and Investigational Dermatology. 2020;13:561–578. Journal
Olazagasti JM, Ma JE, Wetter DA. Clinical features, etiologic factors, associated disorders, and treatment of palmoplantar pustulosis: the Mayo Clinic experience, 1996–2013. Mayo Clin Proc. 2017;92:1351–8. PubMed
Sofia Löfvendahl, Jenny M Norlin, Marcus Schmitt-Egenolf. Comorbidities in palmoplantar pustulosis: a Swedish population-based register study, British Journal of Dermatology. 2023;89(2):230–232. PubMed
Terui T., Kobayashi S., Okubo Y., Murakami M., Zheng R., Morishima H., Goto R., Kimura T. Efficacy and Safety of Guselkumab in Japanese Patients With Palmoplantar Pustulosis: A Phase 3 Randomized Clinical Trial. JAMA Dermatol. 2019;155:1153–61. PubMed
Misiak-Galazka M., Zozula J., Rudnicka L. Palmoplantar Pustulosis: Recent Advances in Etiopathogenesis and Emerging Treatments. Am. J. Clin. Dermatol. 2020;21:355–370. PubMed
Tsiogkas SG, Grammatikopoulou MG, Kontouli KM, Minopoulou I, Goulis DD, Zafiriou E, Bogdanos DP, Patsatsi A. Efficacy of biologic agents for palmoplantar psoriasis: a systematic review and network meta-analysis. Expert Rev Clin Immunol. 2023 Jul-Dec;19(12):1485–98. PubMed
Vernetti AMGB, Massone, C. Palmoplantar pustulosis: Epidemiology, clinical features, and diagnosis. Uptodate. 2024 Dec. Journal